This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi Biotechnology. Active years: 2020-2025.
Company Filing History:
1 out of 1,471 
1 out of 1,540 
1 out of 40 
Years Active: 2020-2025
Title: The Innovations of Moshe E Zilberstein
Introduction
Moshe E Zilberstein is a notable inventor based in North Caldwell, NJ (US). He has made significant contributions to the field of medical treatments, particularly in the areas of rheumatoid arthritis and lupus. With a total of 2 patents, his work has the potential to impact many lives.
Latest Patents
Zilberstein's latest patents include a method of diagnosis and treatment of rheumatoid arthritis. This patent relates to the use of an anti-IL6 receptor antibody for treating rheumatoid arthritis in subjects with serum concentrations of certain biomarkers. Another significant patent is for a method of treating lupus by administering humanized anti-CXCR5 antibodies. This disclosure provides anti-CXCR5 antibodies and their use in the amelioration, treatment, or prevention of lupus, including prophylactic, immunotherapeutic, and diagnostic compositions.
Career Highlights
Throughout his career, Zilberstein has worked with prominent companies such as Sanofi and Sanofi Biotechnology. His experience in these organizations has allowed him to develop and refine his innovative ideas in the medical field.
Collaborations
Some of his notable coworkers include Jeffrey Ming and Roghieh Karimi Anderesi. Their collaboration has likely contributed to the advancements in the projects they have worked on together.
Conclusion
Moshe E Zilberstein's contributions to medical innovation, particularly in the treatment of rheumatoid arthritis and lupus, highlight his importance as an inventor. His patents reflect a commitment to improving healthcare outcomes for patients.